First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

Informations projet

CARE1

N° de convention de subvention: 101104801

DOI

10.3030/101104801

Date de signature de la CE 24 Avril 2023

Date de début 1 Mai 2023

Date de fin 30 Avril 2028

Financé au titre de

• Health

Coût total

€ 5 577 693,50

Contribution de l’UE

€ 5 577 693,50

Coordonné par

INSTITUT GUSTAVE ROUSSY
France

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, reports (10)

Status report - implementation of the digital PRO retrieval and patients monitoring platform
Conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster(1)

Conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster (1)

New QoL questionnaire implemented in CARE1 Pragmatic Clinical Trial
Initial common work plan for scientific collaboration under the ‘Diagnosis and treatment’ cluster
Communication and dissemination plan: Details on the dissemination strategy and action plan including analysis of stakeholder groups, identification of key events and activities
Project Management Plan (PMP): organisation, scope of work, Master Plan, Project Action List, risk register, including a project quality plan (PQP)
Educational material package 1
Standard operating procedure for local PDL1 assessment
First meeting of the PAB minutes
Policy brief formulating recommendations based on the research and innovation strand of the ‘Diagnosis and treatment’ annual cluster meeting (1)

Websites, patent fillings, videos etc. (1)

Visual identity, website and social media: Project branding, introductory project materials, video, infographics, logo are available, website is published and social media accounts operative

Publications

Peer reviewed articles (1)

1717TiP CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma

Auteurs: L. Albiges, C. Suarez Rodriguez, G. Procopio, A. Bex, V. Gruenwald, M. Schmidinger, B. Melichar, G.A. De Velasco Oria, C.D. Bergerot, R. Giles, R. Woodward, A.R. Ferreira, N. Rioux-Leclercq, J. Bonastre, M. Claveau, R. Flippot, B. Escudier, S. Foulon, T.B. Powles
Publié dans: Annals of Oncology, Numéro 35, 2024, ISSN 0923-7534
Éditeur: Elsevier BV
DOI: 10.1016/j.annonc.2024.08.2128